Quarterly report pursuant to Section 13 or 15(d)

Organization and Basis of Presentation (Details Narrative)

v3.22.2.2
Organization and Basis of Presentation (Details Narrative) - USD ($)
 1 Months Ended 6 Months Ended 12 Months Ended
Aug. 17, 2021
Jun. 30, 2022
Dec. 31, 2021
Accumulated deficit   $ (41,500,000)  
Total cash   10,600,000  
Common Stock Exercise Price $ 7.00    
Net Cash Used In Operation   $ 4,400,000 $ 5,700,000
Sale of stock 2,571,428    
Conversion of stock 65,823,015    
Warrants to purchase one share of common stock 2,957,142    
Common stock outstanding   10,102,214 8,328,629
Warrant exercise price   $ 7.00  
Convertible Notes [Member]      
Conversion of stock 32,219    
Accrued interest $ 5,434    
Conversion of stock amount $ 175,000    
Initial Public Offering [Member]      
Sale of stock 2,571,428    
Warrants to purchase one share of common stock 2,571,428    
Combined Offering Price $ 7.00    
Common stock outstanding 1,911,009    
Warrant exercise price $ 7.00    
Incremental number of warrants issued at IPO 385,714    
Option exercise price $ 7.00    
Gross Proceeds from warrants purchase of common stock $ 15,400,000    
Issuance costs $ 2,600,000    
Common Stock [Member]      
Conversion of stock 3,813,973    
Series 1a Preferred Stock      
Conversion of stock 1,419,228    
Warrants exercisable into common stock 69,212